Emmes Europe Competitors and Similar CompaniesClear all

Emmes Europe's competitors and similar companies include CARBOGEN AMCIS, reMYND, CMAB BioPharm and QPS.

	Emmes Europe Emmes Europe (formerly known as Neox CRO) is a company that provides clinical trials with a focus on the pharmaceutical, biotechnology, and medical device sectors.	CARBOGEN AMCIS CARBOGEN AMCIS is a company providing drug development and commercialization services.	reMYND reMYND is a company that specializes in protein misfolding diseases.	CMAB BioPharm CMAB BioPharm is a company that provides process development and manufacturing services for biologic products.	QPS QPS Holdings is a contract research organization that provides preclinical and clinical drug development services.
Founding Date	Founding Date 2004	Founding Date 2006	Founding Date 2002	Founding Date 2017	Founding Date 1995
Type	Type Subsidiary	Type Subsidiary	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech clinical research contractor data management drug development medical devices	Tags Healthcare biotech clinical research contractor drug development	Tags Healthcare biotech clinical research contractor drug development	Tags Healthcare biotech clinical research contractor drug development	Tags Healthcare biotech clinical research contractor drug development
Locations	Locations Praha, CZ HQ Sofia, BG Aachen, DE Budaörs, HU Warszawa, PL București, RO Bratislava, SK see more	Locations Bubendorf, CH HQ Riom, FR Kyoto, JP Veenendaal, NL Aarau, CH Hunzenschwil, CH see more	Locations Leuven, BE HQ	Locations Suzhou, CN HQ Basel, CH	Locations Newark, US HQ Grambach, AT Suzhou Shi, CN Hyderabad, IN Hyderabad, IN Groningen, NL see more
Employees	Employees 1061% decrease	Employees 721	Employees 336% decrease	Employees 44	Employees 6561% increase
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 14.6m (over 5 years ago)	Latest funding round $ 34m (about 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 28.2m	Total funding raised $ 72m	Total funding raised N/A